cogentbio.com (COGT) Quarterly EPS earnings growth

Symbol and logo of brand Cogent Corp (COGT)

The stable operation of research centers and the modernization of drug production lines create a foundation for growth. The quarterly EPS trend confirms this trajectory, where -9.20 shows the value of this parameter. The efficiency of Cogent Biosciences (COGT) is based on partnerships with CMO plants, and business success depends on clinical results rather than economic cycles.

COGT: Cogent Biosciences, Inc. Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/16/2026

Cogent Biosciences (COGT) - metric breakdowns and financial figures

- share price and expert price forecast:
Initial company analysis:Cogent Biosciences
Flagship merchandise of Cogent Corp

The development of targeted therapies to combat systemic mastocytosis defines the financial trajectory of Cogent Biosciences (COGT). This metric measures the percentage change in net earnings per share compared to the same period last year. Analyzing the quarterly EPS growth history allows for the filtering of market noise to reveal actual profitability trends. For a biotech company, this indicator will serve as key confirmation of future pricing power upon the commercialization of drugs. The stable trend on the chart signals rising capitalization and growing investor confidence in the assets.

Who Cogent Biosciences competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Corporation)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BGM (BGM Group Ltd)|XERS (Xeris Biopharma Inc) - Year-over-year net earnings per share trend for the last twelve months|Keros Therapeutics - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months ARCT (Arcturus Therapeutics)|ETON: Quarterly EPS earnings growth|Kamada Ltd (KMDA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Fulcrum Tx|ABEO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Mereo BioPharma Group (MREO)|Quarterly EPS earnings growth protalix.com (PLX)|Quarterly EPS earnings growth PLRX (Pliant Therapeutics Inc)|Quarterly EPS earnings growth Applied Therapeutics APLT|RNTX - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Year-over-year net earnings per share growth for the last 12 months|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth